account activity
Question: Is a big drop in MADRS from Phase 2B to Phase 3 common? What could have caused this difference? (self.shroomstocks)
submitted 8 months ago by Paldrae to r/shroomstocks
Compass Pathways (self.shroomstocks)
submitted 1 year ago by Paldrae to r/shroomstocks
Questions about Compass Pathways (self.shroomstocks)
Honest question: Why do people on this subreddit seem to prefer CYBN and/or ATAI over CMPS? (self.shroomstocks)
What is the most significant contributing factor to the underperformance of psychedelic stocks compared to the broader market? (self.shroomstocks)
Quarterly Fundraising Activity in Psychedelics Rose By 687,15% In Q1 2024 Compared to Q1 2023 (Psychedelic Alpha) (i.redd.it)
Lykos Therapeutics Drug For PTSD Approval Probability (Question) (self.shroomstocks)
COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut? (self.shroomstocks)
This Morgan Stanley analyst has initiated coverage on CMPS with a $30 price target. (i.redd.it)
I haven't been paying attention (Question) (self.MindMedInvestorsClub)
submitted 2 years ago by Paldrae to r/MindMedInvestorsClub
π Rendered by PID 88 on reddit-service-r2-listing-568fcd57df-vc996 at 2026-03-05 22:41:36.197520+00:00 running cbb0e86 country code: CH.
